Metformin Medical Valley

Metformin, the active ingredient in Metformin Medical Valley, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control.

GNH USA supplies Metformin Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is used in the management of disorders related to impaired glucose regulation.

Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. Prediabetes: may help delay progression to overt diabetes when combined with lifestyle measures. Polycystic ovary syndrome: can improve insulin resistance and assist in menstrual regularity.

Metformin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea or vomiting - Diarrhea or loose stools - Abdominal discomfort or cramping - Metallic taste in the mouth

Serious or Rare Side Effects: - Lactic acidosis, a medical emergency - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic dysfunction or elevated liver enzymes - Vitamin B12 deficiency with long‑term use

When prescribing Metformin, clinicians should consider several safety factors. - Renal function: assess eGFR before initiation and monitor periodically. - Hepatic disease: avoid in patients with severe liver impairment. - Lactic acidosis risk: contraindicated in conditions causing hypoxia or severe infection. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Metformin may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Iodinated contrast media: can precipitate acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Alcohol (excessive): heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Diuretics: can affect renal clearance of metformin.